An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

NCT00124241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: telbivudine
DRUG: lamivudine

Sponsor

Novartis

Collaborators

[object Object]